BACKGROUND: Tyrosine phosphorylation of Helicobacter pylori cytotoxin-associated protein of in gastric epithelial cells is reported. The goals of this study are first to examine the occurrence of CagA tyrosine phosphorylation in H. pylori strains isolated from patients with gastric adenocarcinoma and gastritis, and second to clarify the relationship between the diversity of tyrosine phosphorylation motifs and the presence of CagA tyrosine phosphorylation. METHODS: Fifty-eight clinical isolates of H. pylori from patients with gastric adenocarcinoma (29 cases) and gastritis (29 cases) were studied for CagA tyrosine phosphorylation by Western blotting. Sequence diversity of tyrosine phosphorylation motifs was analysed among positive- or negative-CagA tyrosine phosphorylation isolates. RESULTS: Positive CagA tyrosine phosphorylation was found in 93.1% (27 of 29) of strains from gastric adenocarcinoma patients and 51.7% (15 of 29) of strains from gastritis patients (p < 0.001). Intact motifs were found in H. pylori isolates with CagA tyrosine phosphorylation. Of the 16 negative CagA tyrosine phosphorylation isolates, intact tyrosine phosphorylation motifs were found in 15 isolates. CONCLUSIONS: CagA tyrosine phosphorylation, which is significantly greater in strains from gastric adenocarcinoma patients, may play a role in gastric carcinogenesis, and could be a better marker of more virulent strains than the cag pathogenicity island in Asia, where the cag pathogenicity island is present in nearly all H. pylori strains. Sequence diversity of tyrosine phosphorylation motifs on CagA was not related to the presence of tyrosine phosphorylation. The absence of tyrosine phosphorylation motif might result in negative tyrosine phosphorylation phenotypes, but such motifs are not the sole factors associated with CagA tyrosine phosphorylation.
BACKGROUND:Tyrosine phosphorylation of Helicobacter pylori cytotoxin-associated protein of in gastric epithelial cells is reported. The goals of this study are first to examine the occurrence of CagAtyrosine phosphorylation in H. pylori strains isolated from patients with gastric adenocarcinoma and gastritis, and second to clarify the relationship between the diversity of tyrosine phosphorylation motifs and the presence of CagAtyrosine phosphorylation. METHODS: Fifty-eight clinical isolates of H. pylori from patients with gastric adenocarcinoma (29 cases) and gastritis (29 cases) were studied for CagAtyrosine phosphorylation by Western blotting. Sequence diversity of tyrosine phosphorylation motifs was analysed among positive- or negative-CagAtyrosine phosphorylation isolates. RESULTS: Positive CagAtyrosine phosphorylation was found in 93.1% (27 of 29) of strains from gastric adenocarcinomapatients and 51.7% (15 of 29) of strains from gastritispatients (p < 0.001). Intact motifs were found in H. pylori isolates with CagAtyrosine phosphorylation. Of the 16 negative CagAtyrosine phosphorylation isolates, intact tyrosine phosphorylation motifs were found in 15 isolates. CONCLUSIONS:CagAtyrosine phosphorylation, which is significantly greater in strains from gastric adenocarcinomapatients, may play a role in gastric carcinogenesis, and could be a better marker of more virulent strains than the cag pathogenicity island in Asia, where the cag pathogenicity island is present in nearly all H. pylori strains. Sequence diversity of tyrosine phosphorylation motifs on CagA was not related to the presence of tyrosine phosphorylation. The absence of tyrosine phosphorylation motif might result in negative tyrosine phosphorylation phenotypes, but such motifs are not the sole factors associated with CagAtyrosine phosphorylation.
Authors: Alain P Gobert; Thomas Verriere; Thibaut de Sablet; Richard M Peek; Rupesh Chaturvedi; Keith T Wilson Journal: Cell Microbiol Date: 2012-11-07 Impact factor: 3.715
Authors: Steffen Backert; Tobias Schwarz; Stephan Miehlke; Christian Kirsch; Christian Sommer; Terry Kwok; Markus Gerhard; Ulf B Goebel; Norbert Lehn; Wolfgang Koenig; Thomas F Meyer Journal: Infect Immun Date: 2004-02 Impact factor: 3.441
Authors: Jyh-Chin Yang; Hung-Chih Yang; Chia-Tung Shun; Teh-Hong Wang; Chiang-Ting Chien; John Y Kao Journal: Evid Based Complement Alternat Med Date: 2013-04-11 Impact factor: 2.629